Biofrontera Inc. Restructuring Costs
Biofrontera Inc. (BFRI) reported Restructuring Costs of $0 for the 12-month period ending 2022-12-31, per its 8-K filed 2023-10-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2023-10-03
- Biofrontera Inc. restructuring costs for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Biofrontera Inc. restructuring costs for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Biofrontera Inc. restructuring costs for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Biofrontera Inc. restructuring costs for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Biofrontera Inc. restructuring costs for fiscal 2020 was $1.10M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 3 month as first filed | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 9 month as first filed | Restructuring Costs 12 month |
|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | $0.00 derived: sum of 2 quarters · filed 2023-10-03 | $0.00 derived: sum of 3 quarters · filed 2023-10-03 | $0.00 8-K · filed 2023-10-03 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $100.00K derived: sum of 4 quarters · filed 2023-10-03 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $100.00K derived: sum of 3 quarters · filed 2023-10-03 | $300.00K derived: sum of 4 quarters · filed 2023-10-03 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $100.00K derived: sum of 2 quarters · filed 2023-10-03 | $300.00K derived: sum of 3 quarters · filed 2023-10-03 | $800.00K derived: sum of 4 quarters · filed 2023-10-03 | ||
| 2021-12-31 | $100.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | $300.00K derived: sum of 2 quarters · filed 2023-10-03 | $800.00K derived: sum of 3 quarters · filed 2023-10-03 | $800.00K 8-K · filed 2023-10-03 | ||
| 2021-09-30 | $200.00K 10-Q · filed 2022-11-14 | $199.00K 10-Q · filed 2021-11-30 | $700.00K derived: sum of 2 quarters · filed 2022-11-14 | $700.00K 10-Q · filed 2022-11-14 | $654.00K 10-Q · filed 2021-11-30 | $1.24M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $500.00K 10-Q · filed 2022-08-12 | $500.00K 10-Q · filed 2022-08-12 | $1.04M derived: sum of 3 quarters · filed 2022-08-12 | $1.22M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | $300.00K 10-Q · filed 2022-05-13 | $539.00K derived: sum of 2 quarters · filed 2022-05-13 | $720.00K derived: sum of 3 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $239.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-11 | $420.00K derived: sum of 2 quarters · filed 2022-04-11 | $1.10M 10-K · filed 2022-04-11 | |||
| 2020-09-30 | $181.00K 10-Q · filed 2021-11-30 | $861.00K 10-Q · filed 2021-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |